Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters










Publication year range
1.
Biochem J ; 357(Pt 3): 673-85, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11463338

ABSTRACT

STIM1 (where STIM is stromal interaction molecule) is a candidate tumour suppressor gene that maps to human chromosome 11p15.5, a region implicated in a variety of cancers, particularly embryonal rhabdomyosarcoma. STIM1 codes for a transmembrane phosphoprotein whose structure is unrelated to that of any other known proteins. The precise pathway by which STIM1 regulates cell growth is not known. In the present study we screened gene databases for STIM1-related sequences, and have identified and characterized cDNA sequences representing a single gene in humans and other vertebrates, which we have called STIM2. We identified a single STIM homologue in Drosophila melanogaster (D-Stim) and Caenorhabditis elegans, but no homologues in yeast. STIM1, STIM2 and D-Stim have a conserved genomic organization, indicating that the vertebrate family of two STIM genes most probably arose from a single ancestral gene. The three STIM proteins each contain a single SAM (sterile alpha-motif) domain and an unpaired EF hand within the highly conserved extracellular region, and have coiled-coil domains that are conserved in structure and position within the cytoplasmic region. However, the STIM proteins diverge significantly within the C-terminal half of the cytoplasmic domain. Differential levels of phosphorylation appear to account for two molecular mass isoforms (105 and 115 kDa) of STIM2. We demonstrate by mutation analysis and protein sequencing that human STIM2 initiates translation exclusively from a non-AUG start site in vivo. STIM2 is expressed ubiquitously in cell lines, and co-precipitates with STIM1 from cell lysates. This association into oligomers in vivo indicates a possible functional interaction between STIM1 and STIM2. The structural similarities between STIM1, STIM2 and D-STIM suggest conserved biological functions.


Subject(s)
Genome, Human , Neoplasm Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Caenorhabditis elegans/genetics , Cell Adhesion Molecules , Chromosome Mapping , Codon, Initiator , Drosophila melanogaster/genetics , Humans , Membrane Proteins/genetics , Membrane Proteins/isolation & purification , Molecular Sequence Data , Neoplasm Proteins/chemistry , Neoplasm Proteins/isolation & purification , Neoplasm Proteins/metabolism , Protein Biosynthesis , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Stromal Interaction Molecule 1 , Stromal Interaction Molecule 2
2.
J Bone Miner Metab ; 19(1): 4-12, 2001.
Article in English | MEDLINE | ID: mdl-11156472

ABSTRACT

Proteoglycans are suggested to regulate cell adhesion, differentiation and mineralization of hard tissues. In vitro studies have shown that many humoral and local factors regulate proteoglycan synthesis. Among them, parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) have potent stimulating effects on proteoglycan synthesis. However, the exact role of PTHrP on the biosynthesis and metabolism of proteoglycans during skeletal development is not clear. To clarify this point, we examined bony and cartilaginous explants of newborn mice with disrupted PTHrP alleles. Ribs of homozygous PTHrP-knockout mice and wildtype littermates were dissected into bony and cartilaginous regions and metabolically labeled with [35S]sulfate in culture. Radiolabeled proteoglycans were analyzed by column chromatography. The elution profiles of [35S]-labeled proteoglycan from cartilaginous explants did not differ between homozygous PTHrP-knockout mice and wild-type littermates. However, the amount of labeled proteoglycan in homozygous PTHrP-knockout mice was only 4%-5% that of wild-type littermates. In contrast with cartilaginous explants, the amount of labeled proteoglycans in bony explants did not differ between the two genotypes. Interestingly, besides the common major peak (Kd = 0.10-0.16) observed in the bony explants of both genotypes, a minor peak (Kd = 0.42) was specifically present in homozygous PTHrP-knockout mice. This minor peak was earlier than that of free glycosaminoglycan (GAG) chains, suggesting that the core protein, but not GAG chain, was cleaved in the bony explants of homozygous PTHrP. These findings demonstrate a crucial nonredundant role of PTHrP in the regulation of proteoglycan synthesis and metabolism during skeletal development.


Subject(s)
Bone and Bones/metabolism , Cartilage/metabolism , Proteins/genetics , Proteins/physiology , Proteoglycans/biosynthesis , Animals , Animals, Newborn , Bone and Bones/anatomy & histology , Chromatography, Agarose , Chromatography, Ion Exchange , Culture Techniques , Glycosaminoglycans/analysis , Mice , Mice, Knockout , Parathyroid Hormone-Related Protein , Proteoglycans/chemistry , Ribs/anatomy & histology , Ribs/metabolism
3.
J Bone Miner Res ; 16(12): 2182-91, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11760831

ABSTRACT

It is well established that parathyroid hormone-related protein (PTHrP) regulates chondrocytic differentiation and endochondral bone formation. Besides its effect on cartilage, PTHrP and its major receptor (type I PTH/PTHrP receptor) have been found in osteoblasts, suggesting an important role of PTHrP during the process of intramembranous bone formation. To clarify this issue, we examined intramembranous ossification in homozygous PTHrP-knockout mice histologically. We also analyzed phenotypic markers of osteoblasts and osteoclasts in vitro and in vivo. A well-organized branching and anastomosing pattern was seen in the wild-type mice. In contrast, marked disorganization of the branching pattern of bone trabeculae and irregularly aligned osteoblasts were recognized in the mandible and in the bone collar of the femur of neonatal homozygous mutant mice. In situ hybridization showed that most of the osteoblasts along the bone surfaces of the wild-type mice and some of the irregularly aligned osteoblastic cells in the homozygous mice expressed osteocalcin. Alkaline phosphatase (ALP) activity and expression of osteopontin messenger RNA (mRNA) in primary osteoblastic cells did not show significant differences between cultures derived from the mixture of heterozygous mutant and wild-type mice (+/? mice) and those from homozygous mutant mice. However, both mRNA and protein levels of osteocalcin in the osteoblastic cells of homozygous mutant mice were lower than those of +/? mice, and exogenous PTHrP treatment corrected this suppression. Immunohistochemical localization of characteristic markers of osteoclasts and ruffled border formation did not differ between genotypes. Cocultures of calvarial osteoblastic cells and spleen cells of homozygous mutant mice generated an equivalent number of tartrate-resistant acid phosphatase-positive (TRAP+) mononuclear and multinucleated cells and of pit formation to that of +/? mice, suggesting that osteoclast differentiation is not impaired in the homozygous mutant mice. These results suggest that PTHrP is required not only for the regulation of cartilage formation but also for the normal intramembranous bone development.


Subject(s)
Bone Development/physiology , Proteins/metabolism , Adenosine Triphosphatases/metabolism , Animals , Carbonic Anhydrase II/metabolism , Cathepsin K , Cathepsins/metabolism , Cells, Cultured , Female , Gene Expression , Male , Mandible/growth & development , Mandible/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Osteoblasts/cytology , Osteoblasts/drug effects , Osteoblasts/metabolism , Osteocalcin/genetics , Osteoclasts/metabolism , Osteoclasts/pathology , Osteopontin , Parathyroid Hormone-Related Protein , Proteins/genetics , Proteins/pharmacology , Proteins/physiology , Sialoglycoproteins/genetics
4.
Anat Embryol (Berl) ; 202(2): 85-93, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10985428

ABSTRACT

Previous studies using parathyroid hormone-related protein (PTHrP) null mutant mice have indicated severe abnormalities in the endochondral ossification, suggesting that PTHrP affects chondrocyte differentiation. In this study, we found in newborn PTHrP-deficient mice some deformities in the mandible that is formed via intramembranous ossification. The mandibular ramus was bent downwards and a prominent bone crest to which the deep layer of masseter muscle was tendinously attached was observed in the mandibular body. Transmission electron microscopic studies showed that active bone formation was progressing along the tendon fibers of the masseter muscle. The examination of 3-D reconstruction models indicated that the mandibular ramus was bent at the site of muscle attachment, which was shifted in the direction of the muscle fibers. Muscle fiber type analysis using myosin ATPase staining showed that the masseter muscle in the newborn PTHrP-deficient mice contained numerous type 2B fibers, demonstrating premature maturation of this muscle. Based on these findings, we speculated that premature maturation of the masseter muscle leads, probably due to increased tensile forces, to accelerated bone crest formation and subsequent bending of the mandibular ramus. These results further suggest that PTHrP is involved in the regulation of muscle development in normal animals.


Subject(s)
Mandible/abnormalities , Proteins/physiology , Animals , Gestational Age , Immunohistochemistry , Masseter Muscle/chemistry , Masseter Muscle/embryology , Masseter Muscle/ultrastructure , Mice , Mice, Knockout , Microscopy, Electron , Muscle Fibers, Skeletal/chemistry , Muscle Fibers, Skeletal/ultrastructure , Myosins/analysis , Parathyroid Hormone-Related Protein , Proteins/analysis , Proteins/genetics , Receptor, Parathyroid Hormone, Type 1 , Receptors, Parathyroid Hormone/analysis
5.
J Bone Miner Res ; 14(11): 1838-47, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10571683

ABSTRACT

The condylar cartilage, an important growth site in the mandible, shows characteristic modes of growth and differentiation, e.g., it shows delayed appearance in development relative to the limb bud cartilage, originates from the periosteum rather than from undifferentiated mesenchymal cells, and shows rapid differentiation into hypertrophic chondrocytes as opposed to the epiphyseal growth plate cartilage, which has resting and proliferative zones. Recently, attention has been focused on the role of parathyroid hormone-related protein (PTHrP) in modulating the proliferation and differentiation of chondrocytes. To investigate further the characteristic modes of growth and differentiation of this cartilage, we used mice with a disrupted PTHrP allele. Immunolocalization of type X collagen, the extracellular matrix specifically expressed by hypertrophic chondrocytes, was greatly reduced in the condylar cartilage of homozygous PTHrP-knockout mice compared with wild-type mice. In contrast, immunolocalization of type X collagen of the tibial cartilage did not differ. In wild-type mice, proliferative chondrocytes were mainly located in both the flattened cell layer and hypertrophic cell layer of the condylar cartilage, but were limited to the proliferative zone of the tibial cartilage. The number of proliferative chondrocytes was greatly reduced in both cartilages of homozygous PTHrP-knockout mice. Moreover, apoptotic chondrocytes were scarcely observed in the condylar hypertrophic cell layer, whereas a number of apoptotic chondrocytes were found in the tibial hypertrophic zone. Expression of the type I PTH/PTHrP receptor was localized in the flattened cell layer and hypertrophic cell layer of the condylar cartilage, but was absent from the tibial hypertrophic chondrocytes. It is therefore concluded that, unlike tibial hypertrophic chondrocytes, condylar hypertrophic chondrocytes have proliferative activity in the late embryonic stage, and PTHrP plays a pivotal role in regulating the proliferative capacity and differentiation of these cells.


Subject(s)
Chondrocytes/cytology , Mandibular Condyle/cytology , Proteins/physiology , Animals , Apoptosis , Cartilage, Articular/chemistry , Cartilage, Articular/cytology , Cell Division , Chondrocytes/chemistry , Collagen/analysis , Mandibular Condyle/chemistry , Mice , Mice, Knockout , Parathyroid Hormone/analysis , Parathyroid Hormone-Related Protein , Proteins/genetics , Receptor, Parathyroid Hormone, Type 1 , Receptors, Parathyroid Hormone/analysis , Tibia/chemistry , Tibia/cytology
6.
Anat Rec ; 255(4): 452-7, 1999 08 01.
Article in English | MEDLINE | ID: mdl-10409817

ABSTRACT

PTHrP null mutant mice exhibit skeletal abnormalities both in the craniofacial region and limbs. In the growth plate cartilage of the null mutant, a diminished number of proliferating chondrocytes and accelerated chondrocytic differentiation are observed. In order to examine the effect of PTHrP deficiency on the craniofacial morphology and highlight the differential feature of the composing cartilages, we examined the various cartilages in the craniofacial region of neonatal PTHrP deficient mice. The major part of the cartilaginous anterior cranial base appeared to be normal in the homozygous PTHrP deficient mice. However, acceleration of chondrocytic differentiation and endochondral bone formation was observed in the posterior part of the anterior cranial base and in the cranial base synchondroses. Ectopic bone formation was observed in the soft tissue-running mid-portion of the Meckel's cartilage, where the cartilage degenerates and converts to ligament in the course of normal development. The zonal structure of the mandibular condylar cartilage was scarcely affected, but the whole condyle was reduced in size. These results suggest the effect of PTHrP deficiency varies widely between the craniofacial cartilages, according to the differential features of each cartilage.


Subject(s)
Cartilage/abnormalities , Craniofacial Abnormalities/genetics , Craniofacial Abnormalities/pathology , Parathyroid Hormone/deficiency , Proteins/genetics , Animals , Animals, Newborn , Cartilage/embryology , Cartilage/metabolism , Craniofacial Abnormalities/embryology , Facial Bones/abnormalities , Facial Bones/embryology , Facial Bones/metabolism , Female , Heterozygote , Homozygote , Male , Mandibular Condyle/abnormalities , Mandibular Condyle/embryology , Mandibular Condyle/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Parathyroid Hormone/genetics , Parathyroid Hormone-Related Protein , Skull/abnormalities , Skull/embryology , Skull/metabolism , Skull Base/abnormalities , Skull Base/embryology , Skull Base/metabolism
7.
J Mol Endocrinol ; 17(3): 217-23, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8981228

ABSTRACT

In this study, the expression of IGF-II and H19 was examined in the liver, skeletal muscle and choroid plexus of the neonatal rat during normal maturation and after the administration of dexamethasone. If the two genes share common regulatory elements as postulated by an enhancer competition system, their patterns of expression should remain similar throughout maturation and after treatment with dexamethasone. In the liver, down-regulation of IGF-II and H19 during maturation and after dexamethasone administration was shown. This is consistent with the hypothesis that IGF-II and H19 are regulated by common enhancers. In the secretory cells of the choroid plexus, where expression of IGF-II is known to be biallelic, IGF-II was expressed in both untreated and dexamethasone-treated animals, regardless of age, whereas H19 expression was not detectable. This is consistent with the postulate that only one gene from each allele can be engaged by the enhancers. In skeletal muscle, H19 continues to be expressed in the adult after IGF-II is switched off suggesting that IGF-II can also be regulated independently of H19.


Subject(s)
Dexamethasone/pharmacology , Gene Expression Regulation, Developmental/drug effects , Insulin-Like Growth Factor II/genetics , Muscle Proteins/genetics , RNA, Messenger/genetics , RNA, Untranslated , Animals , Animals, Newborn , Choroid Plexus/cytology , Choroid Plexus/metabolism , Liver/metabolism , Muscle, Skeletal/metabolism , RNA, Long Noncoding , Rats , Rats, Sprague-Dawley , Rats, Wistar
8.
J Mol Endocrinol ; 17(2): 149-57, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8938590

ABSTRACT

Secretion of parathyroid hormone-related protein (PTHrP) by sheep fetal parathyroid glands is reported to be an important factor in the maintenance of a placental calcium pump. The aim of the present study was to determine whether the developing rat parathyroid glands express PTHrP or parathyroid hormone (PTH), or both. Hybridisation histochemistry was used to detect transcription of PTHrP and PTH in serial paraffin sections through the 12.5- and 13.5-day rat embryo parathyroid anlage, as well as in sections through the 17.5-day embryonic and adult parathyroid glands. Results show strong expression of PTH in the 13.5-day embryonic parathyroid anlage, as well as in the parathyroid gland of the 17.5-day embryo and adult. Transcription of the PTHrP gene was not detected. The more sensitive technique of reverse transcription PCR was then performed. The pharyngeal region of 11.5-, 12.5- and 13.5-day rat embryos was dissected out and, at each stage, RNA was extracted from these tissues, as well as pooled tissues from the rest of the embryo. RNA that had been extracted from adult thyroid/parathyroid tissue was also tested. After reverse transcription, the resulting cDNAs were amplified by PCR (50 cycles) using specific PTH and PTHrP primers. The results show an abundance of PTH mRNA, specific to the pharyngeal region of the 13.5-day embryo, as well as to adult thyroid/parathyroid tissue. PTHrP expression was detected at very low levels in both parathyroid and extraparathyroid tissues. The presence of immunoreactive PTHrP and immunoreactive PTH in the pharyngeal region and rest of the body of 12.5- and 13.5-day rat embryos was assessed by specific RIAs. Whilst immunoreactive PTHrP was not detected in any of the tissues assayed, immunoreactive PTH was detected only in the pharyngeal region of the 13.5-day embryo. This confirms the results obtained from the gene expression studies. We conclude then that, in the developing rat embryo, PTH rather than PTHrP is more likely to play a role in calcium regulation. This is in contrast with the reported situation in the sheep, and suggests that fundamental species differences in fetal calcium regulation exist in mammals.


Subject(s)
Aging/metabolism , Embryonic and Fetal Development , Gene Expression Regulation, Developmental , Parathyroid Glands/metabolism , Parathyroid Hormone/biosynthesis , Protein Biosynthesis , Animals , Antisense Elements (Genetics) , DNA Primers , Female , Gestational Age , In Situ Hybridization , Male , Parathyroid Glands/embryology , Parathyroid Glands/growth & development , Parathyroid Hormone-Related Protein , Polymerase Chain Reaction , Pregnancy , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Sheep , Transcription, Genetic
9.
J Mol Endocrinol ; 17(2): 159-64, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8938591

ABSTRACT

During pregnancy, a placental calcium pump maintains the fetus in a hypercalcaemic state relative to the mother, a condition which has been thought to facilitate normal development of the fetal skeleton. Based on experiments performed in the sheep, parathyroid hormone-related protein (PTHrP) has been implicated as the hormone responsible for maintaining the placental calcium pump. In the present study on mice in which the PTHrP gene has been ablated by homologous recombination, we have measured both fetal and maternal circulating total and ionised calcium levels, as well as fetal total body calcium, in order to determine whether absence of PTHrP during fetal development has an effect on fetal calcium levels. Our results show that, in fetuses lacking PTHrP, circulating ionised calcium levels are significantly lower than those of heterozygote and wild-type littermates, but circulating total calcium levels show no difference. Total body calcium levels of null mutants are significantly higher than those of normal littermates. The role of PTHrP in maintaining the integrity of the transplacental calcium pump in the rodent thus remains unclear. It may be that the lower levels of fetal blood ionised calcium in mutant animals are due to disruption of the placental pump, but, if this is the case, compensatory mechanisms have operated to allow the excessive calcium deposition seen in the skeletons of these animals. Alternatively, the increased avidity of the bones for calcium may in itself have produced a lower equilibrium level of available ionised calcium.


Subject(s)
Calcium/metabolism , Placenta/physiology , Proteins/physiology , Animals , Chimera , Exons , Female , Genotype , Heterozygote , Kanamycin Kinase , Male , Mice , Mice, Transgenic , Parathyroid Hormone-Related Protein , Phosphotransferases (Alcohol Group Acceptor)/biosynthesis , Phosphotransferases (Alcohol Group Acceptor)/genetics , Pregnancy , Proteins/genetics
10.
J Anat ; 188 ( Pt 1): 65-74, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8655417

ABSTRACT

Insulin-like growth factor II (IGF-II) is expressed during embryogenesis in rodents and humans, but is not produced in most adult tissues. This pattern of expression is closely shared by the gene H19, which lies 3' to IGF-II. This, together with the fact that the genes are reciprocally imprinted, has led to the proposal that the genes are under common transcriptional control by the H19 enhancers during development. In the present study, embryonic stem (ES) cells have been used to generate teratocarcinomas in mice. These tumours generate a wide range of differentiated tissues which have been subjected to hybridisation histochemistry with RNA probes to H19 and IGF-II. Coexpression of the two genes was found in a range of tissues, a pattern consistent with the idea of common transcriptional control. However, there were some areas in which H19 was expressed strongly in comparison with IGF-II and vice versa suggesting the existence of further control elements other than the H19 enhancers.


Subject(s)
Genomic Imprinting , Insulin-Like Growth Factor II/metabolism , Models, Genetic , Muscle Proteins/metabolism , RNA, Untranslated , Teratocarcinoma/metabolism , Animals , Base Sequence , Enhancer Elements, Genetic , Epithelium/physiology , Gene Expression , In Situ Hybridization , Insulin-Like Growth Factor II/genetics , Mice , Molecular Sequence Data , Muscle Proteins/genetics , Muscle, Skeletal/physiology , Neoplasms, Experimental , RNA Probes , RNA, Long Noncoding
11.
Cell Tissue Res ; 280(2): 283-90, 1995 May.
Article in English | MEDLINE | ID: mdl-7781026

ABSTRACT

By means of in situ hybridisation studies, it is shown that parathyroid hormone-related protein (PTHrP) mRNA is strongly expressed in the developing enamel organs of rat teeth. In particular, the cervical loop hybridises strongly with the PTHrP probe and expression is maintained at this site throughout life in the permanently erupting incisor teeth. In mature molar teeth, expression is downregulated to low levels and confined to the epithelial cell rests of Malassez and/or cementoblasts which may derive from these. The gene is also expressed at low levels in the tissue overlying the erupting molars and, thereafter, in the junctional epithelia and connective tissue cells of the epithelial attachment on all tooth surfaces. The premise that PTHrP may undergo post-translational processing and that the resultant products could act in different ways raises the possibility of its exerting multiple paracrine actions during tooth development. These could include the control of cell division and local vascular dilation during development.


Subject(s)
Enamel Organ/metabolism , Gene Expression Regulation, Developmental , Incisor/metabolism , Molar/metabolism , Odontogenesis/genetics , Protein Biosynthesis , Animals , Connective Tissue/metabolism , Enamel Organ/embryology , Enamel Organ/growth & development , Epithelium/metabolism , In Situ Hybridization , Incisor/embryology , Incisor/growth & development , Molar/embryology , Molar/growth & development , Parathyroid Hormone-Related Protein , Protein Processing, Post-Translational , Proteins/genetics , Rats , Rats, Sprague-Dawley
12.
Br J Cancer ; 70(2): 263-9, 1994 Aug.
Article in English | MEDLINE | ID: mdl-8054274

ABSTRACT

The contribution of host-derived growth factors to tumour growth in vivo was studied using the transplantable murine mammary carcinoma, MT1, grown in syngeneic mice. Promotion of growth of the mammary carcinoma by a factor(s) from the host was evident in experiments in which the carcinoma cells were inoculated intraperitoneally. In this environment, tumours develop as multiple solid nodules, each probably arising from an individual cell or a small cluster of cells. Tumour growth was found to occur in the peritoneal cavity following inoculation of 10(3) cells, but an inoculum of as few as ten cells grew if a leucocyte-rich exudate had first been induced. To determine which host-derived growth factors might contribute to growth of MT1, extracts of the tumour were first examined for growth factor activity. Fractionation of tumour extracts by either ion-exchange chromatography or gel filtration revealed several peaks of mitogenic activity, but none of this could be attributed to epidermal growth factor (EGF). Accordingly, an anti-EGF antibody was tested as a putative inhibitor of tumour growth as any effect of this antibody could be ascribed to removal of EGF derived from the host. The antibody was found to have potent anti-tumour activity when tested against MT1 tumours that had been inoculated into the peritoneal cavity. In contrast, the antibody had little effect on growth of the discrete tumour mass which formed when MT1 was transplanted subcutaneously. The results suggest that host-derived EGF contributes to establishment of microcolonies of MT1 carcinoma within the peritoneal cavity. This may be directly, by providing growth factors to supplement those produced by the tumour until it reaches a certain critical mass to sustain autocrine growth, or indirectly, by affecting the production of other growth-stimulatory factors or cytokines.


Subject(s)
Epidermal Growth Factor/physiology , Mammary Neoplasms, Experimental/pathology , Animals , Carcinogens/pharmacology , Cell Division/drug effects , Cell Division/physiology , Disease Models, Animal , Epidermal Growth Factor/pharmacology , Immunoglobulin G/metabolism , Immunoglobulin G/pharmacology , Injections, Subcutaneous , Mice , Peritoneal Cavity/pathology , Rabbits , Sheep , Terpenes/pharmacology , Transplantation, Heterologous
14.
J Reprod Fertil ; 99(2): 343-52, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8107015

ABSTRACT

Hybridization histochemistry and solution hybridization studies were performed to localize the expression of parathyroid hormone-related protein (PTHrP) during implantation in rats. Parallel studies were performed on rat uteri bearing oil-induced deciduomata and on cultured blastocysts. PTHrP mRNA begins to be expressed at day 5.5 of gestation by the uterine epithelium in the anti-mesometrial crypts marking the sites of implantation and in comparable regions during induction of deciduoma. Trophoblastic giant cells express the gene as soon as they are phenotypically recognizable both in vivo and in culture, but PTHrP mRNA cannot be detected in the early blastocyst or in cells of the inner cell mass. Decidual cells produce PTHrP mRNA both in normal gestation and after the induction of deciduomata. In each case, the expression of the gene in decidual cells follows its expression in uterine epithelium by 48 h. The uterine topographical location and time of expression of the PTHrP gene suggests that it plays a part in the implantation of the blastocyst.


Subject(s)
Extraembryonic Membranes/metabolism , Parathyroid Hormone/genetics , Pregnancy, Animal/metabolism , Proteins/genetics , RNA, Messenger/analysis , Uterus/metabolism , Animals , Blastocyst/metabolism , Decidua/metabolism , Embryo Implantation/physiology , Female , Gene Expression , Histocytochemistry , In Situ Hybridization , Parathyroid Hormone-Related Protein , Pregnancy , Pseudopregnancy/metabolism , Rats , Rats, Sprague-Dawley
15.
Development ; 117(4): 1333-43, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8404535

ABSTRACT

The seven in absentia gene (sina) is required for formation of the R7 photoreceptor cell in the developing eye of Drosophila melanogaster. The sina protein contains a putative zinc finger domain and localises to the cell nucleus in Drosophila. We report here the identification of a family of genes in the mouse (designated Siah) with extensive sequence homology to Drosophila sina. The Siah genes fall into two main groups: Siah-1, which consists of four closely related members, two of which appear to be functional, and Siah-2, which contains a single functional member. The predicted Siah proteins show an unusually high degree of conservation with sina over the majority of their lengths, diverging significantly only at their amino terminal ends. The Siah-1 and Siah-2 genes are widely expressed at a low level in the embryo and adult. Analysis of Siah-2 by hybridisation histochemistry shows that it is expressed at a higher level in a restricted number of sites during development, including the olfactory epithelium, retina, forebrain and proliferating cartilage of developing bone. The striking degree of sequence homology observed between the Drosophila and murine genes implies strong conservation pressure on the Siah genes and suggests that they play a significant role in vertebrate development.


Subject(s)
Conserved Sequence/genetics , Drosophila/genetics , Genes/genetics , Mice, Inbred Strains/genetics , Proteins , Amino Acid Sequence , Animals , Blotting, Northern , Blotting, Southern , In Situ Hybridization , Mice , Molecular Sequence Data , Pseudogenes/genetics , Sequence Alignment , Sequence Homology, Amino Acid , Ubiquitin-Protein Ligases
16.
Proc Biol Sci ; 247(1319): 83-7, 1992 Feb 22.
Article in English | MEDLINE | ID: mdl-1349185

ABSTRACT

The expression of the gene coding for peroxisome-proliferator-activated receptor (PPAR), a novel transacting factor belonging to the steroid superfamily, has been determined in the mouse and rat throughout development using hybridization histochemistry. Messenger RNA is demonstrable in the liver and brown fat from the fetal period onwards and, additionally, in the heart, kidney and gut post-natally. It is proposed that the upregulation of transcription of peroxisomal beta oxidation genes in specific tissues follows binding of the receptor to its natural ligand. Thus PPAR may have an important role in cold adaptation and non-shivering thermogenesis as well as in detoxification.


Subject(s)
Microbodies/metabolism , Receptors, Cell Surface/genetics , Adipose Tissue, Brown/growth & development , Adipose Tissue, Brown/metabolism , Animals , Body Temperature Regulation/genetics , Body Temperature Regulation/physiology , Gene Expression , Liver/growth & development , Liver/metabolism , Mice , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Receptors, Cell Surface/metabolism , Tissue Distribution , Transcription Factors/genetics
17.
J Mol Endocrinol ; 6(3): 281-90, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1883489

ABSTRACT

The ontogeny of parathyroid hormone (PTH) and PTH-related protein (PTHrP) gene expression was studied by hybridization histochemistry in the rat at various stages between implantation and full term. PTHrP mRNA was demonstrable in the early postimplantation trophoblastic giant cells but disappeared from this site before 13.5 days. Localized gene expression, detectable by the in-situ technique, began between 12.5 and 15.5 days in embryonic tissues. The distribution of gene expression suggests that PTHrP may be concerned with the process of implantation. Its widespread, yet clearly localized, distribution in embryonic and fetal tissues is consistent with a paracrine or autocrine function which may relate to the transforming growth factor-beta family of growth factors. PTH expression occurred solely in the parathyroid and was detectable in the fetal parathyroid at 13.5 days of gestation.


Subject(s)
Embryonic and Fetal Development/genetics , Parathyroid Hormone/genetics , Proteins/genetics , Animals , Base Sequence , DNA , Gene Expression Regulation , Molecular Sequence Data , Nucleic Acid Hybridization , Parathyroid Hormone-Related Protein , RNA, Messenger/biosynthesis , Rats
18.
J Anat ; 175: 169-79, 1991 Apr.
Article in English | MEDLINE | ID: mdl-2050562

ABSTRACT

Insulin-like growth factor II (IGF-II) gene expression was investigated in the early rat conceptus using in situ hybridisation. IGF-II mRNA has been detected as early as 7 days post coitum in the extraembryonic ectoderm of the egg cylinder (including the ectoplacental cone but excluding the trophoblast bordering the implantation chamber). There was no expression either in the early embryo at this stage or in the implanting blastocyst (5.5 days). At 9.5 days transcription was also detected in extra-embryonic mesodermal derivatives and the visceral yolk sac endoderm, but not in the embryonic region. At 10.5 days transcription was detected in embryonic mesodermal derivatives. High levels were found in the primitive heart, hepatic diverticulum and septum transversum; lower levels were found in the early somites and other primitive mesenchymal derivatives and midgut endoderm. No expression was detected at any stage in derivatives of the embryonic ectoderm, including the neurectoderm. Recent studies of IGF-II, the IGF-II/M-6-P receptor and enzymic extracellular matrix remodelling suggest that the expression of IGF-II in the early rat conceptus may be related to hyaluronate breakdown (with, or without, sulphated glycosaminoglycan synthesis), linked with the aggregation and differentiation of previously migrating mesenchymal cells.


Subject(s)
Gene Expression , Insulin-Like Growth Factor II/genetics , Nucleic Acid Hybridization , RNA, Messenger/analysis , Animals , Female , Oligonucleotide Probes , Pregnancy , Rats , Rats, Inbred Strains
19.
Development ; 109(1): 67-73, 1990 May.
Article in English | MEDLINE | ID: mdl-2170098

ABSTRACT

The insulin-like growth factor II (IGF-II) receptor is identical to the mannose-6-phosphate receptor (M-6-P), but its role as a somatomedin transducer is uncertain. IGF-II/M-6-P receptor expression was studied by in situ hybridization (ISH) in the developing rat. Expression occurs in extra-embryonic membranes at the time of IGF-II mRNA induction and later at paracrine/autocrine sites of IGF-II action (skeletal muscle and perichondrium) in the embryo. Highest levels of receptor mRNA occur in heart and major vessels. Postnatally transcription is strongly down-regulated. This suggests a role for the IGF-II/M-6-P receptor in IGF-II action or turnover during development distinct from its role in lysosomal transport.


Subject(s)
Embryo, Mammalian/metabolism , Fetus/metabolism , RNA, Messenger/biosynthesis , Receptors, Cell Surface/genetics , Animals , Blotting, Northern , Embryonic Development , Endoderm/metabolism , Female , Gestational Age , Mesoderm/metabolism , Pregnancy , RNA, Messenger/genetics , Rats , Receptor, IGF Type 2 , Receptors, Cell Surface/biosynthesis , Receptors, Somatomedin , Yolk Sac/metabolism
20.
Lancet ; 335(8681): 66-9, 1990 Jan 13.
Article in English | MEDLINE | ID: mdl-1967417

ABSTRACT

Parathyroid-hormone-related protein (PTHrP) messenger RNA was identified by in-situ hybridisation in seven tumours complicated by hypercalcaemia. In addition, among samples from normocalcaemic patients, it was commonly found in tumours of types frequently complicated by hypercalcaemia but was not found in tumours that are rarely complicated by hypercalcaemia. Positive results were obtained with both freshly frozen and archive paraffin-embedded material. These findings support the view that PTHrP is a common cause of hypercalcaemia in malignant disorders.


Subject(s)
Hypercalcemia/etiology , Neoplasm Proteins/genetics , Neoplasms/analysis , RNA, Messenger/analysis , RNA, Neoplasm/analysis , DNA Probes , Evaluation Studies as Topic , Humans , Neoplasm Proteins/analysis , Neoplasms/complications , Nucleic Acid Hybridization , Parathyroid Hormone-Related Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...